This week on OrthoBuzz, JBJS is pleased to present another Elite Reviewer profile. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts.
Month: March 2024
Nonoperative treatment outcomes, the efficacy of waterproof cast protectors, and other topics of interest are presented in the new JBJS Guest Editorial What’s New in
What is the incidence of nerve palsy in infants undergoing Pavlik harness treatment for developmental dysplasia of the hip (DDH)? Dr. Matt Schmitz, JBJS Deputy
Editor-in-Chief Dr. Marc Swiontkowski offers this post on a new Level I study in JBJS evaluating the efficacy of diosmin in reducing swelling after total
OrthoBuzz welcomes posts from residents. Have thoughts on a trending topic or recent study? Is there a “life lesson,” big or small, you’d like to
This week on OrthoBuzz, JBJS is pleased to present another Elite Reviewer profile. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts.
Endocrinopathy has been identified as a risk factor for slipped capital femoral epiphysis (SCFE). In young patients with endocrinopathy, what is the incidence of SCFE?
Newswise — Waltham — February 8, 2024 — For patients undergoing total hip arthroplasty (THA), the use of robotic-assisted surgery and surgical navigation techniques is not associated with an
This week on OrthoBuzz, JBJS is pleased to bring back our Elite Reviewer profile series. The Elite Reviewers Program recognizes our best reviewers for their
What happens when a patient declines care but may not have the capacity to provide consent? What defines informed consent? What are ethical obligations and